Why the study?
To investigate the association between the glucose to lymphocyte ratio and 30-day mortality in acute myocardial infarction patients.
Does the glucose to lymphocyte ratio (GLR) predict 30-day mortality in acute myocardial infarction patients?
Does the glucose to lymphocyte ratio (GLR) predict 30-day mortality in acute myocardial infarction patients?
The glucose to lymphocyte ratio has a non-linear relationship with 30-day mortality in AMI patients, with a positive association below a threshold of 4.66.
Answers are grounded in this paper and cite their sources.
GLR was associated with 30-day AMI mortality; hypothesis-generating and requires prospective validation before clinical use.
Aim:To investigate the association between the glucose to lymphocyte ratio (GLR) and 30-day mortality in acute myocardial infarction (AMI) patients. Methods:A retrospective cohort analysis. Two thousand nine hundred and eleven AMI patients were enrolled using the Medical Information Mart for Intensive Care (MIMIC)-IV database. The patients were divided into four groups according to their GLR quantiles. The primary outcome was 30-day mortality. Multivariate Cox proportional risk regression models were used to examine the association between GLR and 30-day mortality. The non-linear relationship between GLR and 30-day mortality was confirmed using a Cox proportional risk regression model fitted by cubic spline function and smooth curve fitting. Results:Of the 2,911 participants, 426 (14.63%) died. The generalized additive model (GAM) showed that the relationship between admission GLR levels and 30-day mortality among AMI patients was non-linear (hazard ratio [HR] 1.01, 95% confidence interval [CI] 1.00–1.02, p = 0.0134). In addition,adjusted multivariable Cox regression analysis confirmed that the admission GLR levels of 3.60-6.06 was independently associated with decreased mortality compared to GLR levels of 0.60–3.59 (HR 1.49, 95% CI 1.02–2.18, p = 0.0409), GLR levels of 6.07–11.03 (HR 1.56, 95% CI 1.07–2.26, p = 0.0203), and GLR levels of 11.04-97.55 (HR 1.69, 95% CI 1.17–2.42, p = 0.0047). A two-piecewise regression model was used to obtain a threshold inflection point value of 4.66. The HR and the 95% CI on the left inflection point were 1.33 and 1.07–1.65, respectively, (p = 0.0116); on the right inflection point, they were 1.01 and 1.01–1.02, respectively, (p = 0.2630). Conclusions:The relationship between the GLR and 30-day mortality was nonlinear in AMI patients. The GLR was positively related with 30-day mortality when the GLR was less than 4.66.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: